IMvigor130 clinical trial in patients (pts) with metastatic urothelial carcinoma (mUC): Analysis of upper tract (UT) and lower tract (LT) subgroups - De Santis, M; Grande, E; Mencinger, M (J Clin Oncol, 2020)
et al.